The mineralocorticoid and glucocorticoid receptors (MR and GR, respectively) are hormone activated transcription factors that impact on the function of virtually every mammalian tissue. This proposal focuses on the mechanistic basis of MR and GR regulation of gene expression, particularly in systems with importance to blood pressure regulation and stress responses. The following hypotheses motivate our future goals: 1) Non-receptor cellular factors are important determinants of the robust and transient induction of a subset of MR- and GR-regulated genes, in particular, SGK1; 2) Synergy control is an important determinant of MR and GR activities, particularly in regulating phenylethanolamine N-methyltransferase (PNMT), the glucocorticoid-regulated enzyme that catalyzes the conversion of norepinephrine to epinephrine. Synergy control is determined by interactions between the DBD and N-terminal domains and requires receptor modification by non-receptor factors, which include the recently discovered ubiquitin-like protein, SUMO1 Based on these considerations, we will: 1) Determine the mechanism of rapid induction of SGK1 gene transcription by MR and GR. We will: (a) identify and characterize hormone response elements involved in the induction of SGK1 gene transcription by MR and GR; (b) determine the role of chromatin modification and transcriptional synergy in the induction of SGK1 gene transcription. 2) Determine the mechanism of down-regulation (""""""""deinduction"""""""") of SGK1 gene expression. We will: (a) Characterize the time course of SGK1 mRNA regulation in rat kidney; (b) determine if new protein synthesis is required for the deinduction of SGK1 gene expression in CCD cells; (C) assess the role of chromatin and non-chromatin factors in SGK1 deinduction; (d) examine the role of mRNA stability in SGK1 deinduction. 3) Determine the mechanistic basis of synergy control and its role in MR and GR activity and specificity. We will: (a) functionally characterize the 5' regulatory region of PNMT; (b) identify cellular factors required for controlling MR and GR synergistic activity; (c) examine the determinants and consequences of SUMO1 modification of GR and MR. Together, these studies will extend our understanding of the gene regulatory mechanisms that underlie blood pressure regulation and responses to stress and potentially lead to new avenues for the prevention and treatment of disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK051151-08
Application #
6741421
Study Section
General Medicine B Study Section (GMB)
Program Officer
Margolis, Ronald N
Project Start
1996-06-01
Project End
2006-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
8
Fiscal Year
2004
Total Cost
$289,854
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Soundararajan, Rama; Wang, Jian; Melters, Daniel et al. (2007) Differential activities of glucocorticoid-induced leucine zipper protein isoforms. J Biol Chem 282:36303-13
Ni, Xi-Ping; Bhargava, Aditi; Pearce, David et al. (2006) Modulation by dietary sodium intake of melanocortin 3 receptor mRNA and protein abundance in the rat kidney. Am J Physiol Regul Integr Comp Physiol 290:R560-7
Bhalla, Vivek; Soundararajan, Rama; Pao, Alan C et al. (2006) Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ. Am J Physiol Renal Physiol 291:F714-21
Soundararajan, Rama; Zhang, Ting Ting; Wang, Jian et al. (2005) A novel role for glucocorticoid-induced leucine zipper protein in epithelial sodium channel-mediated sodium transport. J Biol Chem 280:39970-81
Rozansky, David J; Wang, Jian; Doan, Ninh et al. (2002) Hypotonic induction of SGK1 and Na+ transport in A6 cells. Am J Physiol Renal Physiol 283:F105-13